Iofina Regulatory News (IOF)

8 December 2014

IOFINA PLC

("Iofina" or the "Company")

Exercise of Options and Total Voting Rights

Iofina (AIM: IOF) announces that application has been made for 55,000 new ordinary shares of £0.01 each to be admitted to trading on AIM pursuant to the exercise of options under the Company's Share Option Plan by an option holder (the "Option Exercise"). The options have an exercise price per share of £0.30.

The 55,000 new ordinary shares issued pursuant to the Option Exercise will rank pari passu with the Company's existing ordinary shares and admission to trading on AIM is expected to take place on 11 December 2014.

Total Voting Rights

Following the Option Exercise, the issued share capital of the Company will consist of 127,569,398 ordinary shares of £0.01 each, with one voting right each. The Company does not hold any shares in treasury. Accordingly, the total voting rights in the Company is 127,569,398. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules of the UK Financial Conduct Authority.

For further information, please contact:

Iofina plc

Lance J. Baller, Non-Executive Chairman

Simon W. Holden, Company Secretary

Tel: +44(0)20 3006 3135

Numis Securities - Nominated adviser and joint broker

John Prior / Rupert Krefting / Paul Gillam

Tel: +44 (0)20 7260 1000

GMP Securities - Joint broker

Rob Collins / Emily Morris / Liz Williamson

Tel: +44 (0)20 7647 2800

Yellow Jersey PR - Financial PR

Dominic Barretto / Anna Legge

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has production operations in the United States, specifically in Texas, Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines. For more information, please visit: www.iofina.com